Unity Biotechnology, Inc. Additional Paid in Capital

Unity Biotechnology, Inc. Additional Paid in Capital

Unity Biotechnology, Inc. had Additional Paid in Capital of $321.59 million as of 2018-09-30, per its 10-Q filed 2018-11-07.

Discontinued › Balance Sheet › Equity

us-gaap:AdditionalPaidInCapital · last filed 2018-11-07

• 2018-09-30: Additional Paid in Capital $321.59M.
• 2018-06-30: Additional Paid in Capital $318.76M.
• 2018-03-31: Additional Paid in Capital $5.51M.
• 2017-12-31: Additional Paid in Capital $4.07M.